Laboratory Products
Ready-to-Use Stable Cell Lines
Jan 20 2014
Amsbio has expanded its portfolio of stable cell lines. The new cell lines express endogenous or recombinant proteins and are available in a ready-to-use format to facilitate your research efforts.
Using Amsbio stable cell lines not only provides an optimised solution for manufacture of therapeutic and diagnostic protein, but also for applications in drug screening, pharmacological research and toxicological studies.
The extensive portfolio of ready-to-use stable cell lines available from Amsbio includes: Receptors (RAR a, IGF1 Receptor, Motilin Receptor MLNR...); Ion channels (CFTR, Nav1.7, Kv1.5…); Cell signalling (Notch, JNK, NF-?B, ERK…); Phosphodiesterases (aequorin, CNGA2, PDE1B…); Stem cell related (LGR5, OCT4, LIN28) ; Fluorescent (GFP, RFP, CFP, YFP) ; TetR; Luciferase; CRE recombinase/reporter ; p53 and DNA repair gene knock-down cell lines (PARP1, MUTYH, MSH2, MLH1, XRCC6, BRCA1, NBS1…).
Amsbio also has extensive experience in cell line development and has an excellent track record of developing demanding custom cell lines for academic, biotechnology and pharmaceutical organisations worldwide. Using a lentiviral system, Amsbio scientists with many years of experience in cell line development will quickly establish an optimised cell line according to your specification. All Amsbio custom cell lines are designed specifically to meet client specification as well as our own rigorous internal QC criteria, all within demanding timelines.
Digital Edition
International Labmate 49.6 - Sept 2024
September 2024
Chromatography Articles - HPLC gradient validation using non-invasive flowmeters Mass Spectrometry & Spectroscopy Articles - From R&D to QC, making NMR accessible for everyone: Putting NMR...
View all digital editions
Events
Oct 06 2024 Liverpool, UK
Oct 08 2024 Gothenburg, Sweden
Oct 09 2024 Birmingham, UK
Oct 09 2024 NEC, Birmingham, UK
Oct 15 2024 Milan, Italy